Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Relative Strength
VVOS
Sector
Showing graph for last 90 days.
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Scholar Rock Holding Corporation | 99 | 2.68% | |
Tevogen Bio Holdings Inc. | 98 | 10.89% | |
Summit Therapeutics Inc. | 98 | 1.96% | |
NewAmsterdam Pharma Company N.V. | 98 | 1.58% | |
Anavex Life Sciences Corp. | 97 | 3.69% |
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-5.00
vs -22.00
Q1.23
N/A
NA
vs -6.50
Q2.23
N/A
-3.75
vs -8.27
Q3.23
N/A
-1.75
vs -8.25
Q4.23
N/A
-3.05
vs -5.00
Q1.24
N/A
-1.63
vs NA
Q2.24
N/A
-0.60
vs -3.75
Q3.24
+100%
NA
vs -1.75
Q4.24
N/A
-0.40
vs -3.05
Q1.25
N/A
-0.41
vs -1.63
Sales Growth
YoY
Current
Estimates
Q4.22
-10%
4M vs 4.4M
Q1.23
+11%
3.9M vs 3.5M
Q2.23
-19%
3.4M vs 4.2M
Q3.23
-22%
3.3M vs 4.2M
Q4.23
-18%
3.2M vs 4M
Q1.24
-11%
3.4M vs 3.9M
Q2.24
+19%
4.1M vs 3.4M
Q3.24
+17%
3.9M vs 3.3M
Q4.24
+20%
3.9M vs 3.2M
Q1.25
+20%
4.1M vs 3.4M
Return on Equity
QoQ
Q4.22
-152%
-1.52
vs -0.55
Q1.23
+68%
0.68
vs -1.52
Q2.23
-262%
-2.62
vs 0.68
Q3.23
-4550%
-45.50
vs -2.62
Q4.23
-1036%
-10.36
vs -45.50
Q1.24
-647%
-6.47
vs -10.36
Q2.24
-30%
-0.30
vs -6.47
Q3.24
-34%
-0.34
vs -0.30
Institutionnal Ownership
QoQ
Q1.22
29
29
vs 29
NA
Q2.22
25
25
vs 29
-14%
Q3.22
27
27
vs 25
8%
Q4.22
27
27
vs 27
NA
Q1.23
31
31
vs 27
15%
Q2.23
30
30
vs 31
-3%
Q3.23
26
26
vs 30
-13%
Q4.23
1
1
vs 26
-96%
globenewswire.com
8 hours ago
proactiveinvestors.com
9 hours ago
zacks.com
13 hours ago
proactiveinvestors.com
16 hours ago
globenewswire.com
17 hours ago
seekingalpha.com
23 hours ago